Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson's disease: Potential targets for the development of new therapeutic agents.

Ward, Roberta J.;Lallemand, Frédéric;De Witte, Philippe;Dexter, David T
(2008) Progress in Neurobiology — Vol. 85, n° 2, p. 135-147 (2008)

Files

pdfdocument.pdf
  • Restricted Access
  • Adobe PDF
  • 50 KB
Request a copy

Details

Authors
  • Ward, Roberta J.UCLouvain
    Author
  • Lallemand, Frédéric
    Author
  • De Witte, PhilippeUCLouvain
    Author
  • Dexter, David T
    Author
Abstract
In this short review, neurochemical targets are identified where nicotine, and possibly ethanol, may interact to prevent the occurrence of Parkinson's disease. These are (a) the nicotinic acetycholine receptors present in the nigrostriatal area or on the surface of microglia, (b) monoamine oxidases and (c) inducible nitric oxide synthase. If such induced changes can be verified in clinical studies, this may help in the design of new therapeutic drugs which may be of relevance to diminish the incidence and perhaps the progression of the debilitating condition of Parkinson's disease.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Ward, R. J., Lallemand, F., De Witte, P., & Dexter, D. T. (2008). Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson’s disease: Potential targets for the development of new therapeutic agents. Progress in Neurobiology, 85(2), 135-147. https://doi.org/10.1016/j.pneurobio.2008.03.003 (Original work published 2008)